Table 1.
Phospholipids | Triacylglycerols | Free fatty acids | ||||
---|---|---|---|---|---|---|
Pro | Ama | Pro | Ama | Pro | Ama | |
14:0 | 0.4 ± 0.3 | 3.2 ± 0.3* | 2.2 ± 0.7 | 2.8 ± 0.7 | 1.5 ± 1.2 | 5.7 ± 1.2** |
16:0 | 21.3 ± 3.2 | 28.4 ± 0.9 | 5.8 ± 0.6 | 10.8 ± 0.8** | 6.4 ± 1.5 | 28.3 ± 4.0*** |
18:0 | 8.5 ± 1.0 | 10.3 ± 1.3 | 10.8 ± 1.2 | 10.4 ± 1.6 | 14.4 ± 3.8 | 10.7 ± 0.9 |
Total saturate | 30.2 | 41.9 | 18.8 | 24.0 | 22.3 | 44.7 |
16:1n-9 | 0.7 ± 0.2 | 0.7 ± 0.1 | 1.3 ± 0.3 | 3.7 ± 0.6* | 0.3 ± 0.1 | 0.9 ± 0.2** |
16:1n-7 | 0.6 ± 0.1 | 6.4 ± 0.9** | 0.4 ± 0.2 | 3.8 ± 0.7** | 1.2 ± 0.2 | 5.3 ± 1.2** |
18:1n-9 | 34.9 ± 4.5 | 20.8 ± 1.1* | 25.5 ± 1.5 | 24.5 ± 0.9 | 21.8 ± 3.2 | 17.1 ± 4.1 |
18:1n-7 | 2.8 ± 0.7 | 16.1 ± 2.3** | 2.1 ± 0.6 | 10.7 ± 2.8* | 2.7 ± 0.9 | 17.4 ± 3.0*** |
Total monoenoic | 39.1 | 44.0 | 29.3 | 42.7 | 26.0 | 40.7 |
18:2n-6 | 11.2 ± 2.9 | 3.3 ± 0.9* | 10.9 ± 2.1 | 6.6 ± 0.2* | 15.6 ± 3.8 | 4.6 ± 1.1** |
18:3n-6 | 12.4 ± 2.7 | 0.7 ± 0.3** | 32.6 ± 0.9 | 19.0 ± 2.4*** | 29.1 ± 5.0 | 2.4 ± 1.9*** |
20:3n-6 | 4.5 ± 1.1 | 2.3 ± 0.2 | 3.5 ± 0.9 | 2.4 ± 1.2 | 3.6 ± 0.9 | 2.3 ± 0.8 |
20:4n-6 | 0.8 ± 0.1 | 3.1 ± 0.8* | 0.3 ± 0.1 | 1.5 ± 0.1** | 0.4 ± 0.1 | 2.4 ± 1.4* |
Total n-6 | 28.9 | 9.4 | 47.3 | 29.5 | 48.7 | 11.7 |
18:3n-3 | nd | nd | nd | nd | nd | nd |
20:5n-3 | nd | 0.5 ± 0.3* | nd | nd | nd | nd |
22:5n-3 | 1.3 ± 0.2 | 1.9 ± 0.5 | 1.6 ± 0.5 | 1.7 ± 0.1 | 1.2 ± 0.7 | 1.4 ± 0.6 |
22:6n-3 | 0.7 ± 0.1 | 2.3 ± 1.1 | 3.0 ± 0.6 | 2.1 ± 0.9 | 1.8 ± 0.6 | 1.5 ± 0.6 |
Total n-3 | 1.8 | 4.7 | 4.6 | 3.8 | 3.0 | 2.9 |
Fatty acid composition was determined by GC analysis as described in materials and methods. Data, expressed as mole percent, are means of 3 independent experiments ± SD
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 significant differences between promastigote and amastigote by t test